REBECCA KEENAN: Open Payments
NPI 1164623740 · FLANDERS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,952 in 131 payments from 21 companies in 2025. Trend: 2023 $1,979 · 2024 $1,779 · 2025 $1,952
Food & beverage: $1,952
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $283 |
| AstraZeneca Pharmaceuticals LP | 13 | $247 |
| ABBVIE INC. | 21 | $220 |
| PFIZER INC. | 24 | $187 |
| Exact Sciences Corporation | 7 | $154 |
| Axsome Therapeutics, Inc. | 7 | $132 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Lilly USA, LLC | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
Products named: Ozempic, Cologuard Collection Kit, Auvelity, PREVNAR 20, AIRSUPRA, UBRELVY, REXULTI, Wegovy.
Industry payments across NJ — which companies pay providers there.
